Author:
Lonial S,Durie B,Palumbo A,San-Miguel J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference112 articles.
1. Kuehl WM, Bergsagel PL . Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest 2012; 122: 3456–3463.
2. National Cancer Institute. SEER database. Surveillance, Epidemiology, and End Results Program. 2014 [cited June 30]. Available from http://seer.cancer.gov/ .
3. Becker N . Epidemiology of multiple myeloma. In: Moehler T, Goldschmidt H (eds). Multiple Myeloma: Recent Results in Cancer Research. Springer-Verlag: Berlin Heidelberg, Germany, 2011, 25–35.
4. Walker BA, Wardell CP, Melchor L, Brioli A, Johnson DC, Kaiser MF et al. Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia 2014; 28: 384–390.
5. Kyle RA, Rajkumar SV . Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23: 3–9.
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献